PROGRAM

Conference

Check

List
Business & Development
May 9 (Thu) 13:30~17:00, Rm.308
Session 6. Bio‧Pharmaceutical Global Open Innovation Cooperation and Activation Strategy Part.2
The Trends and Activation Strategies of Global Open Innovation
   This session aims to present recent global open innovation collaboration models and share key success stories to provide direction for the Korean pharmaceutical industry to create more success stories through global open innovation. This session is divided into Part 1 and Part 2, with Part 2 analyzing the trends of global open innovation, along with market access strategies. It also shares key success stories to explore avenues for global expansion collaboration.
Co-organized By KRIPA(한국글로벌의약산업협회)
  • Session Chair
  • Kevin Huh CEO, Korea Innovative Medicines Consortium
  • Opening
  • 13 : 30 ~ 13 : 40
  • KHIDI-Amgen Golden Ticket Signing Ceremony
  • 13 : 40 ~ 14 : 10
  • Global Open Innovation in the Biopharmaceutical Industry
  • Kevin HuhCEO, Korea Innovative Medicines Consortium
  • 14 : 10 ~ 14 : 35
  • The Importance of Market Access Considerations in Early Stage Deal Making
  • Jessie YouVice President, PharmaVentures Ltd
  • 14 : 35 ~ 15 : 00
  • Leveraging the Power of AI to Improve Drug Discovery and Development
  • Helen KimExecutive Director, Business Development, Amgen
  • 15 : 20 ~ 15 : 40
  • MSD's Commitment to Innovation and Partnerships in Life Sciences: Expanding Horizons in the Republic of Korea
  • Koji YashiroDirector, Business Development and Licensing, MSD
  • 15 : 40 ~ 16 : 00
  • Open Innovation in the ADC and TPD Space
  • Sung Joo LeeFounder, Orum Therapeutics, Inc.
  • 16 : 00 ~ 16 : 20
 
Panel Discussion
16 : 20 ~ 16 : 50
 

BIO KOREA 2024 PARTNERS

BIO KOREA 2024 SPONSORS